AI & ChatGPT searches , social queries for RAZPIPADON
Search references for RAZPIPADON. Phrases containing RAZPIPADON
See searches and references containing RAZPIPADON!
Search references for RAZPIPADON. Phrases containing RAZPIPADON
See searches and references containing RAZPIPADON!RAZPIPADON
Chemical compound
Razpipadon (developmental codes CVL-871, PF-06669571, and PW-0464) is a dopamine receptor agonist which is under development for the treatment of dementia-related
Razpipadon
Chemical compound
drugs Glovadalen (UCB-0022) Mevidalen (LY-3154207) PF-06412562 (CVL-562) Razpipadon (CVL-871) Bezard E, Gray D, Kozak R, Leoni M, Combs C, Duvvuri S (2024)
Tavapadon
Pharmaceutical compound
memory disorder drugs List of investigational Parkinson's disease drugs Razpipadon and tavapadon Mevidalen and glovadalen "PF 6412562". AdisInsight. 5 August
PF-06412562
D1 receptor positive allosteric modulator under development for Parkinson's disease
Parkinson's disease drugs DETQ Mevidalen ASP-4345 PF-06412562 (CVL-562) Razpipadon (CVL-871) Tavapadon (CVL-751) "UCB 0022". AdisInsight. Springer Nature
Glovadalen
Group of psychiatric and neurological conditions
Centrally acting dopamine D1-like receptor agonists like tavapadon and razpipadon and D1 receptor positive modulators like mevidalen and glovadalen are
Disorders of diminished motivation
Disorders_of_diminished_motivation
Substance related to dopamine functions
A-86929, adrogolide, dihydrexidine, dinapsoline, doxanthrine, fenoldopam, razpipadon, SKF-81,297, SKF-82,958, SKF-89,145, tavapadon, and trepipam. They have
Dopaminergic
Investigational cognition and memory disorder drugs
(A-87089.0; ABT-089) – α4β2 nicotinic acetylcholine receptor agonist [99] Razpipadon (PF-06669571; PF-6669571; PF06669571; CVL-871; PW-0464) – dopamine D1
List of investigational cognition and memory disorder drugs
List_of_investigational_cognition_and_memory_disorder_drugs
Chemical compound
disorder (ADHD). Glovadalen (UCB-0022) ASP-4345 PF-06412562 (CVL-562) Razpipadon (CVL-871) Tavapadon (CVL-751) "Mevidalen - Eli Lilly and Company". AdisInsight
Mevidalen
Protein-coding gene in humans
reversible control of dopaminergic transmission in wildtype animals. Razpipadon (CVL-871, PF-06669571) Tavapadon (CVL-751, PF-06649751) DETQ – PAM Glovadalen
Dopamine_receptor_D1
Investigational Parkinson's disease drugs
metabotropic glutamate mGlu5 receptor negative allosteric modulator [299] Razpipadon (CVL-871; PF-6669571; PF-06669571; PW-0464) – dopamine D1 receptor agonist
List of investigational Parkinson's disease drugs
List_of_investigational_Parkinson's_disease_drugs
RAZPIPADON
RAZPIPADON
RAZPIPADON
RAZPIPADON
RAZPIPADON
RAZPIPADON
RAZPIPADON
RAZPIPADON
RAZPIPADON